Innovative vaccine production technologies: The evolution and value of vaccine production technologies

20Citations
Citations of this article
107Readers
Mendeley users who have this article in their library.
Get full text

Abstract

This review paper provides an overview of innovative technologies designed to produce bacterial, viral, recombinant subunit, and polysaccharide vaccines, as well as combination vaccines. Advances in this field are illustrated by vaccines against DTP (diphtheria-tetanus-pertussis), influenza, hepatitis B (HepB) and typhoid fever. In addition, technological trends regarding antigens, adjuvants, and preservatives in vaccines are discussed. The progress achieved in vaccine production technologies is especially important for improving the protection of vulnerable populations against infectious diseases. These at-risk groups include infants, the elderly and immunocompromized individuals, as well as people living in developing countries or emerging economies. © 2009 The Pharmaceutical Society of Korea.

Cite

CITATION STYLE

APA

Bae, K., Choi, J., Jang, Y., Ahn, S., & Hur, B. (2009, April). Innovative vaccine production technologies: The evolution and value of vaccine production technologies. Archives of Pharmacal Research. https://doi.org/10.1007/s12272-009-1400-1

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free